Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Provan

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
Diagnostic evaluation of papillary lesions of the breast on core biopsyNirmala Pathmanathan, Ann-Flore Albertini, Pamela J Provan, et al.
Archives of Biochemistry and Biophysics|June 13, 1998
Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen speciesM J Burkitt, H S Bishop, L Milne, et al.
Journal of Clinical Pathology|January 10, 2014
The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancerNirmala Pathmanathan, Rosemary L Balleine, Upali W Jayasinghe, et al.
Genes, Chromosomes & Cancer|September 4, 2010
Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case familiesRosemary L Balleine, Pamela J Provan, Gulietta M Pupo, et al.
Pathology|November 20, 2013
Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33Lucy R Webster, Pamela J Provan, Dinny J Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassificationLucy R Webster, Shu-Fen Lee, Clare Ringland, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
Diagnostic evaluation of papillary lesions of the breast on core biopsyNirmala Pathmanathan, Ann-Flore Albertini, Pamela J Provan, et al.
Archives of Biochemistry and Biophysics|June 13, 1998
Dithiocarbamate toxicity toward thymocytes involves their copper-catalyzed conversion to thiuram disulfides, which oxidize glutathione in a redox cycle without the release of reactive oxygen speciesM J Burkitt, H S Bishop, L Milne, et al.
Journal of Clinical Pathology|January 10, 2014
The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancerNirmala Pathmanathan, Rosemary L Balleine, Upali W Jayasinghe, et al.
Genes, Chromosomes & Cancer|September 4, 2010
Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case familiesRosemary L Balleine, Pamela J Provan, Gulietta M Pupo, et al.
Pathology|November 20, 2013
Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33Lucy R Webster, Pamela J Provan, Dinny J Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassificationLucy R Webster, Shu-Fen Lee, Clare Ringland, et al.
Pageof 5